Clinical Trial

Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia

Study acronym: EagleEye3P
Recruiting
View on ClinicalTrials.gov →
Summary
Tertiary prevention program for women with preeclampsia, HELLP syndrome, kidney disease and pregnancy or associated conditions, including founding of a biobank. (Observational study since no interference with regular path of treatment suggested in national and international guidelines)
Trial Details
NCT Number NCT07151339
Lead Sponsor University Hospital Schleswig-Holstein
Conditions Preeclampsia, HELLP Syndrome, Eclampsia, Kidney Disease
Enrollment 100 participants
Start Date 2024-11-01
Primary Completion 2029-11 (estimated)
Study Completion 2030-11 (estimated)
Updated on ClinicalTrials.gov 2025-09-03